Relapse recovery: The forgotten variable in multiple sclerosis clinical trials

OBJECTIVE: To determine whether basing the decision to initiate immediate vs delayed disease-modifying therapy (DMT) on extent of recovery after initial relapse affects long-term disability accumulation in a multiple sclerosis (MS) evidence-based setting. METHODS: We analyzed the double-blind, place...

Descripción completa

Detalles Bibliográficos
Autores principales: Kantarci, Orhun H., Zeydan, Burcu, Atkinson, Elizabeth J., Conway, Brittani L., Castrillo-Viguera, Carmen, Rodriguez, Moses
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943367/
https://www.ncbi.nlm.nih.gov/pubmed/31848231
http://dx.doi.org/10.1212/NXI.0000000000000653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943367/
https://www.ncbi.nlm.nih.gov/pubmed/31848231
http://dx.doi.org/10.1212/NXI.0000000000000653

Ejemplares similares